Nigar Dursun

Nigar Dursun

Auto-generated profile, based on publicly available information

Nigar Dursun

Kocaeli University Faculty of Medicine

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
NDN. Dursun
N. Dursun
SAS. Akın
S. Akın
EDE. Dursun
E. Dursun
ISI. Sade
I. Sade
FKF. Korkusuz
F. Korkusuz

18 November 2020 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
MDMauricio R Delgado
Mauricio R Delgado
ATAnn Tilton
Ann Tilton
JRJorge Carranza‐Del Río
Jorge Carranza‐Del Río
NDNigar Dursun
Nigar Dursun
MBMarcin Bonikowski
Marcin Bonikowski
TGthe Dysport in PUL study group
the Dysport in PUL study group
Aim: To assess the efficacy and safety of repeat abobotulinumtoxinA injections in reducing upper limb spasticity in children with cerebral palsy (CP).Method: This was a double‐blind, repeat‐cycle study (NCT02106351) in children with CP (2–17y). Children were randomized to receive 2U/kg (control), 8U/kg, or 16U/kg abobotulinumtoxinA injections into the target muscle group (wrist or elbow flexors) and additional muscles alongside occupational therapy via a home‐exercise therapy program (HETP; minimum five 15min sessions/wk). Children received 8U/kg or 16U/kg plus HETP in cycles 2 to 4.Results: During cycle 1, 210 children (126 males, 84 females; mean age [SD] 9y [4y 5mo], range 2–17y; n=70/group) had at least one upper limb abobotulinumtoxinA injection and 209 complied with the HETP. At week 6 of cycle 1, children in the 8U/kg or 16U/kg groups had significantly lower Modified Ashworth scale scores versus the 2U/kg group (primary outcome: treatment differences of –0.4 [p=0.012] and –0.7 [p<0.001] respectively). All groups improved on Physician Global Assessment and children in all groups achieved their treatment goals at least as expected. Therapeutic benefits were sustained during cycles 2 to 4; muscular weakness was the only treatment‐related adverse event reported in at least one child/group (4.3% and 5.7% vs 1.4% respectively).Interpretation: Treatment with 8U/kg or 16U/kg abobotulinumtoxinA significantly reduced upper limb spasticity versus the 2U/kg control dose. Therapeutic benefits of abobotulinumtoxinA plus HETP were sustained with repeat treatment cycles.What this paper adds: AbobotulinumtoxinA injections significantly reduced upper limb spasticity in children with cerebral palsy. Children treated with abobotulinumtoxinA and targeted home exercises showed global improvement and goal attainment. Benefits were sustained over 1 year with repeat cycles of abobotulinumtoxinA and home exercises. AbobotulinumtoxinA injections into the upper limb were well tolerated over 1 year.

28 May 2018 in Physiotherapy Research International
Verified
Journal Article
Closed access
PDF file
DEDursun Erbil
Dursun Erbil
GTGokbel Tugba
Gokbel Tugba
TMTopcu Hasan Murat
Topcu Hasan Murat
AMAkarsu Melike
Akarsu Melike
AMAkyüz Merve
Akyüz Merve
DNDursun Nigar
Dursun Nigar

22 January 2021 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
NDNigar Dursun
Nigar Dursun
TGTugba Gokbel
Tugba Gokbel
MAMelike Akarsu
Melike Akarsu
MBMarcin Bonikowski
Marcin Bonikowski
WPWeronika Pyrzanowska
Weronika Pyrzanowska
EDErbil Dursun
Erbil Dursun

1 February 2024 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
SKSerkan Kablanoğlu
Serkan Kablanoğlu
ÇSÇağrı SADE
Çağrı SADE
CCCIGDEM CEKMECE
CIGDEM CEKMECE
GÖGül Özdin
Gül Özdin
LBLevent Buluç
Levent Buluç
NDNigar Dursun
Nigar Dursun
Objectives: The purpose of this study was to investigate the effectiveness of mirror therapy on pain, sensory, and functional development in addition to conventional rehabilitation and occupational practices in patients with a peripheral nerve injury in the hand. Patients and methods: Twenty-six patients with peripheral nerve injury in the hand were included in this randomized controlled study between November 2017 and May 2018. The patients were randomly assigned to the mirror group (n=14) and the control (n=12) group. Both groups received conventional therapy in our clinic for 45 min a day during weekdays for six consecutive weeks. The mirror group received an additional 10-15 min of visual mirror therapy. Visual Analog Scale (VAS), Duruöz Hand Index, Quick Disabilities of the Arm, Shoulder, and Hand, Jebsen hand function test, and Semmes-Weinstein monofilament test were used for the assessment of pain, hand function, and sensation of the patients at baseline and after treatment. The handgrip strength of the patients was measured with a dynamometer. Results: A total of 20 patients (17 males, 3 females; mean age 31.9±16.5, range 16 to 65 years) completed the study, with 10 in each group. Statistically significant improvement was detected in hand skill functions, such as page-turning (p=0.004), backgammon packing (p=0.023), and heavy object lifting (p=0.029) in the mirror group. A statistically significant decrease was found in total scores of VAS after treatment in both groups (p<0.05). Conclusion: The results imply that mirror therapy integrated with conventional rehabilitation may aid additional benefits on hand functions in peripheral nerve injury. These results demonstrate that mirror therapy can be used in addition to the rehabilitation program of patients with peripheral nerve injury.

1 January 2012 in Turkiye Klinikleri Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
BŞBerna Yildirim Şik
Berna Yildirim Şik
FÇFzt. Çiğdem . Çekmece
Fzt. Çiğdem . Çekmece
NDNigar Dursun
Nigar Dursun
EDErbil Dursun
Erbil Dursun
EBErdener Balikçi
Erdener Balikçi
V.Vet.Mehmet Ali .Gülcü
Vet.Mehmet Ali .Gülcü